734 Endo (Mycophenolate Mofetil 250 mg)
Pill with imprint 734 Endo is Blue & Orange, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Endo Pharmaceuticals Inc..
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; bullous pemphigoid; organ transplant, rejection prophylaxis; graft-versus-host disease (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 734 Endo
Mycophenolate Mofetil
- Imprint:
- 734 Endo
- Strength:
- 250 mg
- Color:
- Blue & Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Endo Pharmaceuticals Inc.
- Inactive Ingredients:
- ammonia
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
potassium hydroxide
povidone
propylene glycol
shellac
Note: Inactive ingredients may vary.
More about mycophenolate mofetil
- Mycophenolate mofetil Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 46 Reviews
- Drug class: selective immunosuppressants
Consumer resources
- Mycophenolate mofetil oral/injection
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
- Mycophenolate Mofetil Injection Solution
- Mycophenolate Mofetil Oral Suspension
- ... +2 more
Other brands: CellCept
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
